Occupational Hazzard in the Cath Lab

Original Title: Occupational Health Risks in Cardiac Catheterization Laboratory Workers. Reference: Maria Grazia Andreassi et al. Circ Cardiovasc Interv. 2016 Apr;9(4).

 

Orthopedic lesions and radiation exposure are among the health risks Cath Lab staff take. However, the potential occupational hazard in quantitative terms is still unclear. The purpose of this study was to examine the prevalence of health issues among cath lab personnel (interventional cardiology/ electrophysiology) and correlate them with length of exposure.

We used a self-administered questionnaire to collect demographic information, work related information, possible lifestyle confounding factors, medications, and health status. A total of 746 subjects were evaluated, 466 (281 male; 44 ±9 years) exposed and 280 unexposed (179 male; 43±7 years). Exposed personnel included 218 interventional cardiologists and electrophysiologists, 191 nurses and 57 technicians working for a median of 10 years (range 5 to 24 years). In the exposed group, there was a significantly higher rate of skin lesions (P=0.002), orthopedic illness (P<0.001), cataract (P=0.003), hypertension (P=0.02), and hypercholesterolemia (P<0.001) vs. the non-exposed group. In addition, there was a clear gradient unfavorable for exposed physicians over exposed technicians or nurses.

In the exposed physicians, adjusted OR ranged from 1.7 for hypertension (95% CI: 1 to 3; P=0.05), 2.9 for hypercholesterolemia (95% CI: 1–5; P=0.004), 4.5 for cancer (95% CI: 0.9 to 25; P=0.06), and 9 OR for cataract (95% CI: 2 to 41; P=0.004).

Conclusion
Health problems are more frequently observed in cath lab staff than in unexposed staff. These data show the need to spread out the culture of safety in the cath lab across all staff involved.

More articles by this author

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...